Drug firms call on FDA to add to guidance on trial enrichment

03/25/2013 | OutSourcing-Pharma.com

Large drug firms including Merck, Eli Lilly & Co. and Pfizer urged the FDA to bolster its draft guidance on enrichment measures for clinical trials with more examples involving additional therapeutic areas. Pharmaceutical companies also called for increased guidance involving diagnostics.

View Full Article in:

OutSourcing-Pharma.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN